![Meghan Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meghan Thomas
Teknisk/Vetenskaplig/F&U Direktör på
ARGENICA THERAPEUTICS LIMITED
Profil
Meghan Thomas is currently Vice President-Clinical Development at Argenica Therapeutics Ltd. since 2022.
Formerly, Dr. Thomas was Vice President-Clinical Programs & Operations at Zelira Therapeutics Ltd. Education includes undergraduate and doctorate degrees from The University of Western Australia and an undergraduate degree from the University of Edith Cowan.
Aktiva positioner av Meghan Thomas
| Företag | Position | Start |
|---|---|---|
| ARGENICA THERAPEUTICS LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2022-04-04 |
Tidigare kända positioner av Meghan Thomas
| Företag | Position | Slut |
|---|---|---|
| ZELIRA THERAPEUTICS LIMITED | Verksamhetschef | - |
Meghan Thomass utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
13
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Edith Cowan
 University of Edith Cowan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zelira Therapeutics Ltd.
 Zelira Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and supplies cannabinoid-based medicines for the treatment of human diseases and disorders | Health Technology |
Argenica Therapeutics Ltd.
 Argenica Therapeutics Ltd. BiotechnologyHealth Technology Develops novel neuro protective therapeutics to reduce brain damage | Health Technology |
